Lv51
1404 积分 2021-09-17 加入
Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin
2天前
已完结
One‐Component Cationic Lipids for Systemic mRNA Delivery to Splenic T Cells
3天前
已完结
Anti-PEG antibodies: Current situation and countermeasures
6天前
已完结
Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo
6天前
已完结
Lipid-based Nanocarriers for mRNA Delivery: Vital Considerations and Applications
6天前
已完结
Phospholipid Type Regulates Protein Corona Composition and In Vivo Performance of Lipid Nanodiscs
10天前
已完结
Protein Engineering Strategies for Improved Pharmacokinetics
13天前
已完结
PEGylation of therapeutic proteins
13天前
已完结
Nanobodies as a powerful platform for biomedicine
13天前
已完结
Monoclonal antibodies and cancer therapy
14天前
已完结
皖公网安备34019202002308
